has been cited by the following article(s):
[1]
|
Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so Far
|
|
Frontiers in Cell and …,
2021 |
|
|
[2]
|
Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii
|
|
2020 |
|
|
[3]
|
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain
|
|
2019 |
|
|
[4]
|
Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
|
|
Molecular imaging,
2018 |
|
|
[5]
|
Znaczenie kinazy sfingozyny-1 oraz sfingozyno-1-fosforanu w doświadczalnym modelu choroby Parkinsona oraz w farmakologicznej cytoprotekcji
|
|
Thesis,
2017 |
|
|
[6]
|
Sphingolipids as a new factor in the pathomechanism of preeclampsia–Mass spectrometry analysis
|
|
PLOS ONE,
2017 |
|
|
[7]
|
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
|
|
Molecular Imaging and Biology,
2016 |
|
|
[8]
|
Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
|
|
Current Medicinal Chemistry,
2016 |
|
|
[9]
|
IL-17–Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory …
|
|
2015 |
|
|
[10]
|
IL-17–Producing Vg4 gd T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory …
|
|
2015 |
|
|
[11]
|
IL-17–Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
|
|
The Journal of Immunology,
2015 |
|
|
[12]
|
IL-17–Producing Vg4 gd T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
|
|
2015 |
|
|
[13]
|
An update on the biology of sphingosine 1-phosphate receptors
|
|
Journal of lipid research,
2014 |
|
|
[14]
|
Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
|
|
2014 |
|
|
[1]
|
Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii
The Journal of Antibiotics,
2020
DOI:10.1038/s41429-020-0351-0
|
|
|
[2]
|
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain
Proceedings of the National Academy of Sciences,
2019
DOI:10.1073/pnas.1820466116
|
|
|
[3]
|
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Molecular Imaging and Biology,
2016
DOI:10.1007/s11307-016-0944-y
|
|
|